Home > R&D Offer > In Vitro Evaluation of Drugs

In Vitro Evaluation of Drugs

Many In vitro Models and Biological Samples are Available within the CALYM Consortium for the Identification and Validation of New Biological Targets or Molecules

- CALYM has rich biological collections of human cryopreserved viable cells from lymphomas and reactive tissues (CeVi collection), tumors (slides, paraffin blocks, frozen, Tissue Micro Array, DNA / RNA), blood (plasma, DNA / RNA ) for molecular profile characterization, quantification studies, immunohistochemistry, etc.

- Our teams have acquired and developed numerous lymphoma cell lines (B-cell, T-cell, mantle cell lymphomas...) for in vitro exploration and identification studies of biological targets: more than 80 cell lines (established and primary).

- New custom models can be developed.

Several Ex vivo Models are also Available for Functional Studies

CRISPR / CAS9, primary cell co-culture system ...

CALYM has many Cutting-edge Technological Platforms to Assess the Potential Effect of New Drug Candidates, to Define Initial Safety and Efficacy Profile

  • Bioinformatics
  • OMICS (genomics, transcriptomics, proteomics, metabolomics, lipidomics)
  • Microscopy (multiphotonic, fluo, MET, MEB, confocal, NanoSims 50…)
  • Flow cytometry, immunophenotyping, immunomonitoring (ISO 9001- NFX 50-900

► More about our technological platforms

Contact us:+33 (0)4 72 24 41 71, by e-mail
or by submitting your question in the contact form